Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients

Abstract Continuous subcutaneous (SubQ) treprostinil is an effective therapy for pediatric patients diagnosed with pulmonary hypertension (PH). To date, the clinical characteristics and factors associated with failure to tolerate this therapy have not been described. The purpose was to describe pati...

Full description

Bibliographic Details
Main Authors: Julia McSweeney, Elizabeth Colglazier, Jasmine Becerra, Brienne Leary, Kathleen Miller‐Reed, Stephen Walker, Katy Tillman, Melissa Magness, Michelle Ogawa, Whitney Bannon, Tisha Kivett, Emma O. Jackson, Anne Davis, Cathy Shepard, Susan Richards, Elise Whalen, Shannon Engstrand, Zachary DiPasquale, Jean A. Connor
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Pulmonary Circulation
Subjects:
advanced practice nursing
prostacyclin
pulmonary hypertension
treprostinil
Online Access:https://doi.org/10.1002/pul2.12224

Internet

https://doi.org/10.1002/pul2.12224

Similar Items